Search details
1.
Author Correction: PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas.
Nature
; 565(7738): E4, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30532003
2.
PAK signalling drives acquired drug resistance to MAPK inhibitors in BRAF-mutant melanomas.
Nature
; 550(7674): 133-136, 2017 10 05.
Article
in English
| MEDLINE | ID: mdl-28953887
3.
Evaluation of the effect of store-and-forward teledermatology on in-person health care system utilization in a safety-net public health and hospital system.
J Am Acad Dermatol
; 85(4): 1026-1028, 2021 10.
Article
in English
| MEDLINE | ID: mdl-33482252
4.
Pseudoprogression in a patient with metastatic melanoma treated with PD-1 and LAG-3 inhibition.
Melanoma Res
; 2024 Apr 18.
Article
in English
| MEDLINE | ID: mdl-38640504
5.
Neural Crest-Like Stem Cell Transcriptome Analysis Identifies LPAR1 in Melanoma Progression and Therapy Resistance.
Cancer Res
; 81(20): 5230-5241, 2021 10 15.
Article
in English
| MEDLINE | ID: mdl-34462276
6.
Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma.
Clin Cancer Res
; 24(19): 4771-4784, 2018 10 01.
Article
in English
| MEDLINE | ID: mdl-29563139
7.
Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cells.
Oncotarget
; 8(15): 25395-25417, 2017 Apr 11.
Article
in English
| MEDLINE | ID: mdl-28445987
8.
Mitochondrial biogenesis meets chemoresistance in BRAF-mutant melanoma.
Mol Cell Oncol
; 3(4): e1179381, 2016 Jul.
Article
in English
| MEDLINE | ID: mdl-27652325
9.
Durable Clinical Response to Larotrectinib in an Adolescent Patient With an Undifferentiated Sarcoma Harboring an STRN-NTRK2 Fusion.
JCO Precis Oncol
; 22018.
Article
in English
| MEDLINE | ID: mdl-32913990
Results
1 -
9
de 9
1
Next >
>>